Clareo Health | Trials

Login Get started

Finding studies

1–20 of 179

UnknownAn Innovative Supportive Care Model for Dementia and Traumatic Brain InjuryThere are an increasing number of people in the U.S. with Alzheimer's disease and other dementias.NCT04495686Charlottesville, Virginia UnknownFeasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's DiseaseThis study will test G:DATA, a simple computer game designed to diagnose Alzheimer's Disease, in three different groups of people, some of whom have Alzheimer's Disease.NCT06047340Carmarthen, Wales Active not recruitingBrainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics of multiple-ascending intravenous (IV) doses of RO7126209…NCT04639050Atlantis, Florida and 36 others Enrolling by invitationLocalized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)Scalp to cortex distance (SCD), as a key technological parameter of brain stimulation, has been highlighted in the guidelines of non-invasive brain stimulation.NCT05967390Hong Kong CompletedDominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects who are known to have an Alzheimer's…NCT04623242Birmingham, Alabama and 24 others CompletedAgeing Gut Brain InteractionsThis research project will address a desperate need for evidence on how diet could be used to treat and improve symptoms of Alzheimer's disease (AD).NCT03593941Aberdeen, Grampian CompletedDementia Risk Prediction Model: Development and ValidationAt present, there is no treatment for dementia that changes the course of the disease.NCT03943641Edinburgh, Midlothian CompletedThe Feasibility of Florbetapir QuantitationThe overall objective of the study is to assess the feasibility of implementing a quantitative process of florbetapir F 18 scan interpretation.NCT01946243Philadelphia, Pennsylvania UnknownImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)The proposed research project aims to answer the question "Are immersive technology systems effective in the management and treatment of patients with BPSD?".NCT06072014Manila, National Capital Region RecruitingNatives Engaged in Alzheimers Research - 'Ike KupunaThis study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function…NCT05534607Honolulu, Hawaii and 2 others Active not recruitingMulti-Center Study of Sensory Stimulation to Improve Brain FunctionThe Overture Study is a randomized, controlled, single-blind multi-center clinical trial using the GammaSense Stimulation system to study safety, tolerability, and efficacy in…NCT03556280Delray Beach, Florida and 4 others CompletedA Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseThe study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer's disease.NCT05891496Sun City, Arizona and 11 others CompletedA Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's DiseaseThe main purpose of this study is to evaluate safety, tolerability and immunogenicity of the vaccine ALZ-101 against Alzheimer's Disease.NCT05328115Turku CompletedPain Processing and Pain Reporting in Patients With Alzheimer's DiseaseThe study investigates pain processing and pain reporting in patients with Alzheimers disease compared to healthy participants.NCT03709238Aarhus, Central Jutland RecruitingEvaluating the Effectiveness of the Health App Recommendation ToolThis study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features and matches them to the needs…NCT07216716Pittsburgh, Pennsylvania CompletedPK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy VolunteersThe present pharmacokinetic study is designed to further characterise the pharmacokinetics of the RSG XR formulation and aims to assess dose proportionality, strength equivalence…NCT00733785Berlin Active not recruitingA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to…NCT07170150Phoenix, Arizona and 146 others TerminatedOpen-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersThis is a Phase III, multicenter, open-label extension, single-group study in male and female outpatients with mild-to-moderate Alzheimer's disease (AD) who have completed either…NCT00490568Litchfield Park, Arizona and 271 others UnknownProtecting Alzheimer Caregivers Using Technology Through Staying SharpPROACTS is a Phase I/II study to assess the efficacy of AARP Staying Sharp online health program, focusing on the health of non-professional home-based caregivers of persons with…NCT05260515 CompletedThe STEP 4Life TrialThe objective of this study is to test the feasibility of using behavioral economic interventions (gamification with social incentives) targeting daily step counts to prevent or…NCT05069155Philadelphia, Pennsylvania

Data from ClinicalTrials.govTerms